NCT06485908 Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06396481 Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06323408 Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas Status NOT_YET_RECRUITING Phase N/A
NCT06161519 PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications Status RECRUITING Phase PHASE1/PHASE2
NCT05934630 Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors Status TERMINATED Phase N/A
NCT05835687 Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05672043 Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China Status RECRUITING Phase N/A
NCT05535166 Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma Status RECRUITING Phase PHASE2
NCT05278208 Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05131763 NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors Status UNKNOWN Phase PHASE1
NCT05128903 Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05125666 Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection Status UNKNOWN Phase PHASE2
NCT05106296 Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer Status RECRUITING Phase PHASE1
NCT05057702 Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma Status RECRUITING Phase NA
NCT04978727 A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04730349 A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT04696029 DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma Status RECRUITING Phase PHASE2
NCT04661384 Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04541082 Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms Status RECRUITING Phase PHASE1
NCT04521946 Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer Status WITHDRAWN Phase PHASE1